[Corrigendum] Isostrychnopentamine, an Indolomonoterpenic Alkaloid From Strychnos Usambarensis, With Potential Anti-Tumor Activity Against Apoptosis-Resistant Cancer Cells

International Journal of Oncology - Greece
doi 10.3892/ijo.2013.2213
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Isostrychnopentamine, an Indolomonoterpenic Alkaloid From Strychnos Usambarensis, With Potential Anti-Tumor Activity Against Apoptosis-Resistant Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2010English

Scoparone Exerts Anti-Tumor Activity Against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity

PLoS ONE
Multidisciplinary
2013English

Anti-Cancer Activity of New Benzyl Isoquinoline Alkaloid From Saudi Plant Annona Squamosa

BMC Chemistry
Chemistry
2019English

The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

Anti-Prostate Cancer Activity of a Β-Carboline Alkaloid Enriched Extract From Rauwolfia Vomitoria

International Journal of Oncology
Cancer ResearchOncology
2006English

Activity of 2-Aryl-2-(3-Indolyl)acetohydroxamates Against Drug-Resistant Cancer Cells

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Inhibiting PAD2 Enhances the Anti-Tumor Effect of Docetaxel in Tamoxifen-Resistant Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Anti-Tumor Activity of New Quinoline Derivatives in Human Breast Cancer T47D Cells

International Journal of Cancer Research
Cancer ResearchOncology
2006English

Transfer of siRNA Against XIAP Induces Apoptosis and Reduces Tumor Cells Growth Potential in Human Breast Cancer in Vitro and in Vivo

Breast Cancer Research and Treatment
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy